(b) Angle closure
| Disease staging | ≥180° appositionally closed (where posterior TM not visible [grade 1]) | Ocular hypertension and/or peripheral anterior synechiae | Ganglion cell, optic nerve, and visual field damage |
|---|---|---|---|
| PACS | + | − | − |
| PAC | + | + | − |
| PACG | + | + | + |
PAC, primary angle closure; PACS, primary angle closure suspect; PACG, primary angle closure glaucoma.
The above definitions could be used to guide decisions regarding the target IOP range (i.e., for patients with more advanced disease and/or evidence of rapidly progressing disease, targeted IOP should be in the lower targeted range). To achieve this, patients may require a more aggressive therapy from initiation of therapy; see Figure 3, suggested range for initial target IOP, and Figure 5, proposed treatment algorithm.